Trishula Therapeutics
0 followers
‌
Trishula Therapeutics is a clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.
Industries
Headquarters
Employees
Links
Org chart
Anil Singhal
President & CEO
Anil Singhal
Collapse
Alan Luk
VP, CMC
Anh Tran
Head of Clinical Operations
Siddhartha Mitra
Chief Medical Officer
Mukesh K
Sr Clinical Data Manager
Thomas Mueller
Vice President, Head Of Immuno-oncology And Translational Sciences
Similar companies
GRAIL
27 followers
Cytokinetics
11 followers
BridgeBio
2 followers
Neogene Therapeutics
2 followers
Thermo Fisher Scientific
147 followers
Gilead Sciences
121 followers
Biogen
108 followers
Regeneron
89 followers
Agilent Technologies
61 followers
Vertex Pharmaceuticals
50 followers
Alexion Pharmaceuticals
33 followers
Discover companies